EU to grant $US1b to global fund, pharma firms donate to US ADAPs

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.423, 2003-01, pp. : 11-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Global Fund for AIDS, Tuberculosis and Malaria has rejected the US's request for an emergency grant of $US50 million

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 640-641, 2011-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Pharma industry to fund Rx discounts for US elderly

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 290, 2000-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

CD4+ cell count criteria could control costs in US ADAPs

Inpharma, Vol. 1, Iss. 1568, 2006-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

CD4+ cell count criteria could control costs in US ADAPs

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 518, 2006-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Immunisation fund tops $US1b, WHO calls for free anti-TB drugs

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 422, 2003-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite